Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Solid Biosciences

Solid Biosciences
2013 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
SLDB STOCK SYMBOL
2 INVESTMENTS
$6.04 SHARE PRICE (As of Friday Closing)
Description

Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices. In the assistive device program, the company focuses on producing a wearable assistive device for patients with DMD.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 161 First Street
  • Third Floor
  • Cambridge, MA 02142
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Solid Biosciences’s full profile, request a free trial.

Solid Biosciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$5.23 - $54.84 $214M $6.18 -$2.56 796K 35.4M

Solid Biosciences Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 180,522 1,004,675
Revenue 0 0 0 0
EBITDA (87,630) (73,851) (52,949) (24,086)
Net Income (88,503) (74,798) (52,118) (21,539)
Total Assets 120,234 139,597 76,193 40,636
Total Debt 991 1,032 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Solid Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Solid Biosciences‘s full profile, request access.

Request full access to PitchBook

Solid Biosciences Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intarcia Therapeutics Venture Capital-Backed Boston, MA 000 00.000 0000000000 0 00.000
0000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000000 Corporation Melbourne, Australia 00 00000 000000000 00000
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
0000000 0000000000 Venture Capital-Backed Watertown, MA 0000 00000000000 0000
To view this company’s complete list of competitors, request access »

Solid Biosciences Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00 30-Mar-2017 000000000000000000 Biotechnology 0000 00000
Solid GT Angel (individual) 0000 Biotechnology 0000 00000
To view this company’s complete investment and acquisition history, request access »

Solid Biosciences Subsidiaries (1)

Company Name Industry Location Founded
00000 00 Biotechnology Cambridge, MA 0000
To view this company’s complete subsidiary history, request access »

Solid Biosciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Solid Biosciences‘s full profile, request access.

Request full access to PitchBook

Solid Biosciences Executive Team (10)

Name Title Board
Seat
Contact
Info
Ilan Ganot Co-Founder, President, Chief Executive Officer & Board Member
Jennifer Ziolkowski Chief Financial Officer
Alvaro Amorrortu Chief Operating Officer
Joel Schneider Ph.D Chief Technology Officer & Head of Exploratory Research & Development
Carl Morris Ph.D Chief Scientific Officer

1 Former Executive

You’re viewing 5 of 10 executives. Get the full list »

Solid Biosciences Board Members (9)

Name Representing Role Since Contact
Info
Adam Koppel Ph.D Bain Capital Board Member 000 0000
Adam Stone Perceptive Advisors Board Member 000 0000
Andrey Zarur Ph.D Self Co-Founder & Chairman 000 0000
Ilan Ganot Solid Biosciences Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Lynne Sullivan Solid Biosciences Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 9 board members. Get the full list »